Sino Medical Sciences Technology Inc.
SSE:688108.SS
10.77 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -3.889 | -43.4 | -173.31 | -131.299 | 22.493 | 90.038 | 89.19 | 66.146 | 28.65 |
| Depreciation & Amortization
| 78.163 | 62.81 | 63.166 | 65.41 | 38.303 | 28.05 | 20.725 | 17.673 | 15.895 |
| Deferred Income Tax
| 0 | 0 | -48.034 | -34.37 | 0.403 | 6.273 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.248 | 0.586 |
| Change In Working Capital
| 17.278 | 11.954 | -50.641 | -21.523 | 5.564 | 13.335 | -14.266 | -18.994 | -6.613 |
| Accounts Receivables
| 10.314 | 18.862 | 7.73 | 100.117 | -13.747 | 5.972 | 3.268 | -22.377 | -15.053 |
| Inventory
| 18.698 | -14.527 | -18.38 | -27.789 | 3.647 | -13.931 | -21.61 | -12.723 | -4.005 |
| Accounts Payables
| 0 | 3.026 | 8.043 | -59.48 | 15.261 | 15.022 | 0 | 0 | 0 |
| Other Working Capital
| -11.734 | 4.592 | -48.034 | -34.37 | 0.403 | 6.273 | 7.344 | -6.271 | -2.609 |
| Other Non Cash Items
| 39.688 | 25.476 | 49.472 | 27.278 | 4.152 | 6.182 | 1.913 | 5.498 | 4.312 |
| Operating Cash Flow
| 131.24 | 56.84 | -111.313 | -60.133 | 70.513 | 137.605 | 97.562 | 70.323 | 42.244 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -70.017 | -67.669 | -110.762 | -158.449 | -112.782 | -180.045 | -98.875 | -76.255 | -44.323 |
| Acquisitions Net
| -20.353 | -125.664 | 0.021 | -25.841 | -8.952 | 180.05 | -7.481 | -1 | 44.414 |
| Purchases Of Investments
| -17 | -57 | -150 | -306 | -655 | -235 | -525 | -580 | -10 |
| Sales Maturities Of Investments
| 17.073 | 57.292 | 171.81 | 303.036 | 656.266 | 236.948 | 792.521 | 321.208 | 11.369 |
| Other Investing Activites
| 0.833 | 0 | 0 | 0.663 | 0.221 | -180.045 | 1.434 | 0.132 | -44.323 |
| Investing Cash Flow
| -89.464 | -193.041 | -88.932 | -186.591 | -120.246 | -178.091 | 162.599 | -335.914 | -42.864 |
| Financing Activities: | |||||||||
| Debt Repayment
| 7.8 | 69 | 30.5 | 5 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 319.82 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -4.11 | -2.007 | -0.94 | -0.029 | -41 | 0 | 0 | -9 | -16 |
| Other Financing Activities
| 57.778 | 55.322 | 87.298 | -14.404 | -1.791 | 304.351 | 7.418 | 338.458 | 0 |
| Financing Cash Flow
| 61.468 | 122.316 | 116.858 | -9.433 | -43.124 | 304.351 | 7.418 | 329.458 | -16 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.209 | -0.898 | -0.946 | -0.75 | -0.858 | -0.492 | -0.05 | -0.126 | -0.454 |
| Net Change In Cash
| 103.035 | -14.783 | -84.333 | -256.908 | -93.716 | 263.373 | 267.529 | 63.741 | -17.074 |
| Cash At End Of Period
| 291.675 | 188.64 | 203.423 | 287.757 | 544.665 | 638.38 | 375.007 | 107.478 | 43.738 |